Literature DB >> 20857543

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Francesco Violi, Roberto Cangemi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20857543     DOI： 10.1056/NEJMc1006581

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

1.  Oral Recombinant Methioninase Prevents Nonalcoholic Fatty Liver Disease in Mice on a High Fat Diet.

Authors:  Yoshihiko Tashiro; Qinghong Han; Yuying Tan; Norihiko Sugisawa; Jun Yamamoto; Hiroto Nishino; Sachiko Inubushi; Y U Sun; Hyein Lim; Takeshi Aoki; Masahiko Murakami; Yoshihisa Takahashi; Michael Bouvet; Robert M Hoffman
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Schisandra chinensis Baill, a Chinese medicinal herb, alleviates high-fat-diet-inducing non-alcoholic steatohepatitis in rats.

Authors:  Zheng Yao; Xiao-Chen Liu; Ying-Er Gu
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

3.  Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.

Authors:  Vanessa Souza-Mello
Journal:  World J Hepatol       Date:  2015-05-18

4.  Redox nanoparticles as a novel treatment approach for inflammation and fibrosis associated with nonalcoholic steatohepatitis.

Authors:  Akiko Eguchi; Toru Yoshitomi; Milos Lazic; Casey D Johnson; Long Binh Vong; Alexander Wree; Davide Povero; Bettina G Papouchado; Yukio Nagasaki; Ariel E Feldstein
Journal:  Nanomedicine (Lond)       Date:  2015-05-28       Impact factor: 5.307

5.  Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Tiantian Song; Yujiao Jia; Zelin Li; Fei Wang; Luping Ren; Shuchun Chen
Journal:  Diabetes Ther       Date:  2021-05-17       Impact factor: 2.945

Review 6.  Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.

Authors:  Hyunmi Kim; Da Som Lee; Tae Hyeon An; Hyun-Ju Park; Won Kon Kim; Kwang-Hee Bae; Kyoung-Jin Oh
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  Water Soluble Vitamin E Administration in Wistar Rats with Non-alcoholic Fatty Liver Disease.

Authors:  Irene P Tzanetakou; Ilias P Doulamis; Laskarina-Maria Korou; George Agrogiannis; Ioannis S Vlachos; Alkisti Pantopoulou; Dimitri P Mikhailidis; Efstratios Patsouris; Ioannis Vlachos; Despina N Perrea
Journal:  Open Cardiovasc Med J       Date:  2012-08-10

8.  Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management.

Authors:  Anna Di Sessa; Grazia Cirillo; Stefano Guarino; Pierluigi Marzuillo; Emanuele Miraglia Del Giudice
Journal:  Pediatric Health Med Ther       Date:  2019-08-23

9.  Greater serum carotenoid levels associated with lower prevalence of nonalcoholic fatty liver disease in Chinese adults.

Authors:  Yi Cao; Cheng Wang; Jun Liu; Zhao-min Liu; Wen-hua Ling; Yu-ming Chen
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

10.  Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells.

Authors:  Yixuan Sun; Xinlu Yuan; Feifei Zhang; Yamei Han; Xinxia Chang; Xi Xu; Yu Li; Xin Gao
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.